Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 46c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.13), $0.46 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $3.56 million, versus $0 reported last year.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'
• Alloy (ALOY) files mixed shelf